Skip to content
Screener

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.74B+7.4%
Danaher logo
DanaherDHR
$870M+56.8%
Bruker logo
BrukerBRKR
-$52M-784%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$17.93M-152%
Revvity logo
RevvityRVTY
$51.82M-3.9%
Agilent Technologies logo
Agilent TechnologiesA
$362M+7.7%

Other financials

Income statement

See full
Revenue$321.2M+1.3%
Gross profit$211.4M+6.3%
Operating income$74.3M—
EPS (diluted)$0.35—

Balance sheet

See full
Cash & equivalents$264.7M+63.2%
Total debt$289.1M-34.9%
Total equity$2.1B+9.9%
Total assets$2.6B+1.1%

Cash flow

See full
Operating cash flow$95.4M-2.8%
CapEx$8.5M+73.4%
Free cash flow$86.9M-6.8%

Valuation

See full
Market cap$11.35B+17.4%
Enterprise value$11.38B+14.7%
P/E62.4×—
P/S9.3×+1.4×

Profitability

See full
Gross margin65.8%+1.0pp
Operating margin20.7%—
Net margin15%—
FCF margin21.7%+0.6pp

Returns & leverage

See full
Return on equity9%—
Debt / equity0.1×-0.1×
Current ratio4.5×+1.1×

Where this comes from

Reported directly by Bio-Techne Corp. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The source filing: Bio-Techne Corp.’s 10-K, filed August 24, 2026. Open the filing →

Filed
Aug 24, 2026, 4:31 PM EDT
Fiscal year
FY2026
Accession
0001104659-26-100322

FAQ

What is Bio-Techne Corp.'s net income?
Bio-Techne Corp. (TECH) reported net income of $54.62M in Q2 2026.
What is the long-term trend for Bio-Techne Corp.'s net income?
Over 3 years (2022 to 2026), Bio-Techne Corp.'s net income has grown at a -12.6% compound annual growth rate (CAGR), from $272.05M to $181.86M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Bio-Techne Corp.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude